Ge Health Care Technologies Inc. GEHC
We take great care to ensure that the data presented and summarized in this overview for GE HealthCare Technologies Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GEHC
Top Purchases
Top Sells
About GEHC
Insider Transactions at GEHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2025
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
4,620
-7.3%
|
$351,120
$76.68 P/Share
|
|
Sep 11
2025
|
Roland Rott CEO, Imaging |
BUY
Exercise of conversion of derivative security
|
Direct |
5,341
+7.71%
|
$288,414
$54.71 P/Share
|
|
Sep 01
2025
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
1,834
-2.06%
|
$133,882
$73.73 P/Share
|
|
Sep 01
2025
|
Philip Rackliffe CEO, AVS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,891
-2.77%
|
$138,043
$73.73 P/Share
|
|
Sep 01
2025
|
Taha Kass Hout Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,897
-2.16%
|
$211,481
$73.73 P/Share
|
|
Sep 01
2025
|
Adam Y Holton Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
464
-2.69%
|
$33,872
$73.73 P/Share
|
|
Sep 01
2025
|
Kenneth R. Stacherski Chief Enterprise Oper. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-1.07%
|
$65,116
$73.73 P/Share
|
|
Sep 01
2025
|
Peter J Arduini President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,346
-3.22%
|
$828,258
$73.73 P/Share
|
|
Sep 01
2025
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,238
-2.65%
|
$236,374
$73.73 P/Share
|
|
Sep 01
2025
|
Frank R Jimenez GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,079
-2.17%
|
$224,767
$73.73 P/Share
|
|
Aug 15
2025
|
Kenneth R. Stacherski Chief Enterprise Oper. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,217
+19.61%
|
-
|
|
Jun 01
2025
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,712
-13.57%
|
$679,840
$70.54 P/Share
|
|
May 28
2025
|
Risa J Lavizzo Mourey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+23.34%
|
-
|
|
May 28
2025
|
Catherine A Lesjak Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+25.33%
|
-
|
|
May 28
2025
|
Lloyd Howell Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+25.33%
|
-
|
|
May 28
2025
|
Tomislav Mihaljevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+25.33%
|
-
|
|
May 28
2025
|
Anne T Madden Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,848
+16.06%
|
-
|
|
May 28
2025
|
Rodney F Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,848
+16.06%
|
-
|
|
May 28
2025
|
Watkin Phoebe L. Yang Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,092
+25.33%
|
-
|
|
May 28
2025
|
William J Stromberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,129
+16.27%
|
-
|
Last 12 Months Summary
Buy / Acquisition
276K
Shares
From
22
Insiders
| Grant, award, or other acquisition | 258K shares |
|---|---|
| Exercise of conversion of derivative security | 18.6K shares |
Sell / Disposition
137K
Shares
From
14
Insiders
| Payment of exercise price or tax liability | 131K shares |
|---|---|
| Open market or private sale | 6.48K shares |